Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 18 Source: CRO
- €4.2 billion turnover
-
€255.3 million
profit - 10,400 employees
-
31st Dec 17 Source: CRO
- €4.1 billion turnover
-
€229.2 million
profit - 10,400 employees
- 4 more years available »
Ranking
By Turnover
(€4.2 billion)- 25th in Top Companies
- 6th in Health
- 5th in Pharma
By Employees
(10,400)- 19th in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.2 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- Mar 18 Diaceutics confirms it will seek London listing
- Mar 18 Bear Grylls and Netflix team up for interactive series
- Mar 18 FTSE 100 exporters rise after sterling declines
- Mar 18 Boeing faces growing scrutiny in Ethiopian crash probe
- Mar 18 Lyft seeks valuation of $23bn in New York IPO